Vitamin D supplementation may lower BP in overweight elderly: Study

Published On 2024-11-20 02:30 GMT   |   Update On 2024-11-20 02:31 GMT
Advertisement

Vitamin D supplementation may lower BP in overweight elderly suggests a study published in the Journal of the Endocrine Society.

Supplementation with vitamin D and calcium can reduce systolic and diastolic blood pressure in older individuals with overweight, particularly in those with a body mass index (BMI) > 30 and those diagnosed with hypertension. Large cohort data have provided epidemiologic evidence linking vitamin D deficiency to a higher risk for cardiovascular disorders, including hypertension; however, evidence on the beneficial effects of vitamin D supplementation on blood pressure outcomes remains inconclusive. A post hoc analysis of a randomized controlled trial was conducted to investigate the effect of two doses of cholecalciferol (vitamin D3) on blood pressure in individuals aged 65 years or older with a BMI > 25 and serum vitamin D levels of 10-30 ng/mL. A total of 221 participants were recruited through outpatient departments, clinics, and advertisements in the greater Beirut area and received calcium supplementation in combination with either a low dose (600 IU/d, as recommended by the Institute of Medicine [IOM]) or a high dose (3750 IU/d) of vitamin D3. Blood pressure measurements were taken at baseline, 6 months, and 12 months using a SureSigns VS3 monitor. Participants were also stratified by BMI and hypertension status to assess the effects of vitamin D and calcium on blood pressure. Systolic and diastolic blood pressures were significantly reduced with vitamin D supplementation in the overall cohort (mean difference, 3.5 and 2.8 mm Hg, respectively; P = .005 and P = .002, respectively), with the effect more prominent in those in the high-dose vitamin D group. Participants with a BMI > 30 experienced reductions in both systolic and diastolic blood pressures in the overall cohort (P < .0001 and P = .01, respectively); although the systolic blood pressure was significantly reduced with both high- and low-dose vitamin D, the diastolic blood pressure decreased in the high-dose group only. Patients with hypertension benefited from all doses of vitamin D, regardless of the BMI. Systolic blood pressure at 6 and 12 months was significantly predicted by BMI and baseline systolic blood pressure measurements, although not by the dose of vitamin D received.

Advertisement

“The study found vitamin D supplementation may decrease blood pressure in specific subgroups such as older people, people with obesity, and possibly those with low vitamin D levels,” said study author, Ghada El-Hajj Fuleihan, MD, MPH, of the American University of Beirut Medical Center in Beirut, Lebanon, in a news release. “High vitamin D doses compared to the IOM’s recommended daily dose did not provide additional health benefits.”



Reference:

Maya Rahme, Laila Al-Shaar, Hani Tamim, Ghada El-Hajj Fuleihan, Blood Pressure Decreases in Overweight Elderly Individuals on Vitamin D: A Randomized Trial, Journal of the Endocrine Society, Volume 8, Issue 12, December 2024, bvae168, https://doi.org/10.1210/jendso/bvae168

Keywords:

Vitamin D, supplementation, lower BP, overweight, elderly, study, Journal of the Endocrine Society, Maya Rahme, Laila Al-Shaar, Hani Tamim, Ghada El-Hajj Fuleihan, Blood Pressure




Tags:    
Article Source : Journal of the Endocrine Society

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News